Milestone Pharmaceuticals is trading at $1.05 (6.6% down) today, giving back a portion of its recent pre-market strength in the absence of fresh company-specific catalysts.
- There are no new earnings reports, FDA decisions, or analyst updates driving today's price action.
- The stock appears to be drifting lower on light news flow following a period of short-term volatility.
- The downward move occurs while broader markets trade mixed and the healthcare sector remains relatively firm.